Adamas Pharmaceuticals, Inc.:
Launched GOCOVRI™ for LID in patients w/ Parkinson’s disease. Late-stage pipeline includes ADS-5102 in P3 for MS walking impairment and ADS-4101, high-dose, modified release lacosamide, which completed P1 for partial onset seizures in patients with epilepsy.
1900 Powell St, Ste 1000
Emeryville, CA 94608
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Stock Market Data
Market Data copyright © 2017 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by